| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |